BIOMAT Database Logo BIOMAT Database Logo

[Treatment of acute pancreatitis with somatostatin and total parenteral nutrition in a chronic uremic patient undergoing hemodialysis]. 1988

C Tozzo, and M Morosetti, and V Mazzarella, and C Meloni, and L Meschini, and S Manca, and F Pisani, and G Milito, and M Taccone-Gallucci, and C U Casciani

UI MeSH Term Description Entries
D010195 Pancreatitis INFLAMMATION of the PANCREAS. Pancreatitis is classified as acute unless there are computed tomographic or endoscopic retrograde cholangiopancreatographic findings of CHRONIC PANCREATITIS (International Symposium on Acute Pancreatitis, Atlanta, 1992). The two most common forms of acute pancreatitis are ALCOHOLIC PANCREATITIS and gallstone pancreatitis. Acute Edematous Pancreatitis,Acute Pancreatitis,Pancreatic Parenchyma with Edema,Pancreatic Parenchymal Edema,Pancreatitis, Acute,Pancreatitis, Acute Edematous,Peripancreatic Fat Necrosis,Acute Edematous Pancreatitides,Acute Pancreatitides,Edema, Pancreatic Parenchymal,Edematous Pancreatitides, Acute,Edematous Pancreatitis, Acute,Fat Necrosis, Peripancreatic,Necrosis, Peripancreatic Fat,Pancreatic Parenchymal Edemas,Pancreatitides, Acute,Pancreatitides, Acute Edematous,Parenchymal Edema, Pancreatic,Peripancreatic Fat Necroses
D010289 Parenteral Nutrition, Total The delivery of nutrients for assimilation and utilization by a patient whose sole source of nutrients is via solutions administered intravenously, subcutaneously, or by some other non-alimentary route. The basic components of TPN solutions are protein hydrolysates or free amino acid mixtures, monosaccharides, and electrolytes. Components are selected for their ability to reverse catabolism, promote anabolism, and build structural proteins. Hyperalimentation, Parenteral,Intravenous Hyperalimentation,Nutrition, Total Parenteral,Parenteral Hyperalimentation,Total Parenteral Nutrition,Hyperalimentation, Intravenous
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D005260 Female Females
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013004 Somatostatin A 14-amino acid peptide named for its ability to inhibit pituitary GROWTH HORMONE release, also called somatotropin release-inhibiting factor. It is expressed in the central and peripheral nervous systems, the gut, and other organs. SRIF can also inhibit the release of THYROID-STIMULATING HORMONE; PROLACTIN; INSULIN; and GLUCAGON besides acting as a neurotransmitter and neuromodulator. In a number of species including humans, there is an additional form of somatostatin, SRIF-28 with a 14-amino acid extension at the N-terminal. Cyclic Somatostatin,Somatostatin-14,Somatotropin Release-Inhibiting Hormone,SRIH-14,Somatofalk,Somatostatin, Cyclic,Somatotropin Release-Inhibiting Factor,Stilamin,Somatostatin 14,Somatotropin Release Inhibiting Factor,Somatotropin Release Inhibiting Hormone
D014511 Uremia A clinical syndrome associated with the retention of renal waste products or uremic toxins in the blood. It is usually the result of RENAL INSUFFICIENCY. Most uremic toxins are end products of protein or nitrogen CATABOLISM, such as UREA or CREATININE. Severe uremia can lead to multiple organ dysfunctions with a constellation of symptoms. Uremias

Related Publications

C Tozzo, and M Morosetti, and V Mazzarella, and C Meloni, and L Meschini, and S Manca, and F Pisani, and G Milito, and M Taccone-Gallucci, and C U Casciani
[Total parenteral nutrition in the treatment of acute pancreatitis].
January 1984, Annali dell'Ospedale Maria Vittoria di Torino,
C Tozzo, and M Morosetti, and V Mazzarella, and C Meloni, and L Meschini, and S Manca, and F Pisani, and G Milito, and M Taccone-Gallucci, and C U Casciani
[TOTAL PARENTERAL NUTRITION IN A PREGNANT PATIENT WITH ACUTE PANCREATITIS AND LIPOPROTEIN LIPASE DEFICIENCY].
October 2015, Nutricion hospitalaria,
C Tozzo, and M Morosetti, and V Mazzarella, and C Meloni, and L Meschini, and S Manca, and F Pisani, and G Milito, and M Taccone-Gallucci, and C U Casciani
Total parenteral nutrition in severe acute pancreatitis.
April 1991, Journal of the American College of Nutrition,
C Tozzo, and M Morosetti, and V Mazzarella, and C Meloni, and L Meschini, and S Manca, and F Pisani, and G Milito, and M Taccone-Gallucci, and C U Casciani
Serum ribonuclease activity in patients during parenteral nutrition, chronic hemodialysis and acute pancreatitis.
October 1977, Klinische Wochenschrift,
C Tozzo, and M Morosetti, and V Mazzarella, and C Meloni, and L Meschini, and S Manca, and F Pisani, and G Milito, and M Taccone-Gallucci, and C U Casciani
Treatment of pancreatic fistulas with somatostatin and total parenteral nutrition.
September 1989, Scandinavian journal of gastroenterology,
C Tozzo, and M Morosetti, and V Mazzarella, and C Meloni, and L Meschini, and S Manca, and F Pisani, and G Milito, and M Taccone-Gallucci, and C U Casciani
[Total enteral nutrition vs. total parenteral nutrition in patients with severe acute pancreatitis].
May 2007, Revista espanola de enfermedades digestivas,
C Tozzo, and M Morosetti, and V Mazzarella, and C Meloni, and L Meschini, and S Manca, and F Pisani, and G Milito, and M Taccone-Gallucci, and C U Casciani
[Role of somatostatin and parenteral nutrition in the treatment of acute pancreatitis. Personal experience].
March 1989, Minerva chirurgica,
C Tozzo, and M Morosetti, and V Mazzarella, and C Meloni, and L Meschini, and S Manca, and F Pisani, and G Milito, and M Taccone-Gallucci, and C U Casciani
Prolonged total parenteral nutrition in a pregnant woman with acute pancreatitis.
June 1984, Journal of clinical gastroenterology,
C Tozzo, and M Morosetti, and V Mazzarella, and C Meloni, and L Meschini, and S Manca, and F Pisani, and G Milito, and M Taccone-Gallucci, and C U Casciani
Treatment of hyperlipidemic pancreatitis in pregnancy with total parenteral nutrition.
December 1982, Gastroenterology,
C Tozzo, and M Morosetti, and V Mazzarella, and C Meloni, and L Meschini, and S Manca, and F Pisani, and G Milito, and M Taccone-Gallucci, and C U Casciani
A meta-analysis of enteral nutrition and total parenteral nutrition in patients with acute pancreatitis.
January 2011, Gastroenterology research and practice,
Copied contents to your clipboard!